Exhibiton Event
Jeisys Medical Validates Clinical Value of Flagship Energy-Based Devices at 'KOREA DERMA 2025
Proving Technological Superiority Through Clinical Presentations of Flagship Devices
SEOUL, South Korea – Jeisys Medical Inc., a prominent global developer of medical aesthetic energy-based devices, successfully showcased the clinical efficacy and technological advancements of its flagship product lines at 'KOREA DERMA 2025,' held at Coex Magok.
As one of Asia's largest and most influential international dermatological conferences, KOREA DERMA 2025 attracted approximately 5,000 dermatologists and global industry buyers from 65 countries, providing an ideal premier platform for clinical exchange.
During the three-day event, Jeisys Medical elevated its brand authority by delivering a unified user experience and organizing high-caliber scientific sessions focused on its core energy-based technologies: DENSITY (Monopolar/Bipolar Radiofrequency), LinearZ (High-Intensity Focused Ultrasound), and POTENZA (Microneedle RF). The sessions were strictly designed around peer-reviewed clinical data to enhance product understanding and foster international medical networks.
The academic programs featured live-podium presentations from renown international medical experts. Key opinion leaders (KOLs) from Taiwan delivered comprehensive lectures on procedural techniques, while clinical experts from South Korea and Brazil shared their extensive real-world experiences and treatment modalities, highlighting the clinical safety and superior tightening and lifting outcomes of the DENSITY system.
In tandem with the scientific lectures, Jeisys Medical’s exhibition booth served as a major hub for collaborative networking. The booth recorded a significant turnout of 986 dermatologists and global buyers, reflecting intense industry interest in the company's proprietary innovations.
"KOREA DERMA 2025 served as a definitive stage to showcase our advanced technical capabilities and data-driven clinical excellence to the global medical community," said an official from Jeisys Medical. "Through our flagship-focused scientific lectures, we successfully fostered deeper relationships with global practitioners and solidified our position as a trusted leader in the global medical aesthetic market."
As one of Asia's largest and most influential international dermatological conferences, KOREA DERMA 2025 attracted approximately 5,000 dermatologists and global industry buyers from 65 countries, providing an ideal premier platform for clinical exchange.
During the three-day event, Jeisys Medical elevated its brand authority by delivering a unified user experience and organizing high-caliber scientific sessions focused on its core energy-based technologies: DENSITY (Monopolar/Bipolar Radiofrequency), LinearZ (High-Intensity Focused Ultrasound), and POTENZA (Microneedle RF). The sessions were strictly designed around peer-reviewed clinical data to enhance product understanding and foster international medical networks.
The academic programs featured live-podium presentations from renown international medical experts. Key opinion leaders (KOLs) from Taiwan delivered comprehensive lectures on procedural techniques, while clinical experts from South Korea and Brazil shared their extensive real-world experiences and treatment modalities, highlighting the clinical safety and superior tightening and lifting outcomes of the DENSITY system.
In tandem with the scientific lectures, Jeisys Medical’s exhibition booth served as a major hub for collaborative networking. The booth recorded a significant turnout of 986 dermatologists and global buyers, reflecting intense industry interest in the company's proprietary innovations.
"KOREA DERMA 2025 served as a definitive stage to showcase our advanced technical capabilities and data-driven clinical excellence to the global medical community," said an official from Jeisys Medical. "Through our flagship-focused scientific lectures, we successfully fostered deeper relationships with global practitioners and solidified our position as a trusted leader in the global medical aesthetic market."